ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $217,962,000 | -7.1% | 17,521,066 | +2.2% | 0.06% | -6.8% |
Q3 2016 | $234,654,000 | +13301.1% | 17,140,492 | +5616.7% | 0.06% | – |
Q3 2015 | $1,751,000 | +60.6% | 299,832 | +127.5% | 0.00% | – |
Q2 2015 | $1,090,000 | +409.3% | 131,768 | +323.7% | 0.00% | – |
Q4 2014 | $214,000 | -10.1% | 31,100 | -29.5% | 0.00% | – |
Q3 2014 | $238,000 | – | 44,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 1,331,100 | $23,281,000 | 8.28% |
DAFNA Capital Management LLC | 191,215 | $3,344,000 | 4.89% |
Redmile Group, LLC | 1,277,109 | $22,337,000 | 3.94% |
BB BIOTECH AG | 3,115,371 | $54,488,000 | 3.92% |
SECTORAL ASSET MANAGEMENT INC | 5,292,682 | $92,569,000 | 2.74% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 565,956 | $9,899,000 | 1.76% |
OAK RIDGE INVESTMENTS LLC | 2,645,781 | $46,275,000 | 1.45% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,265,104 | $22,127,000 | 1.04% |
Tekla Capital Management LLC | 412,965 | $7,223,000 | 0.98% |
Private Capital Advisors, Inc. | 127,600 | $2,232,000 | 0.83% |